BioShares Biotechnology ETFs Complete Semi-Annual Rebalance and Recomposition

Following rebalance, BBC and BBP funds offer increased diversity of holdings

BioShares ETFs to Ring The Nasdaq Stock Market Opening Bell on March 4, 2015

The BioShares ETF team will visit the Nasdaq MarketSite in Times Square to celebrate the listing of the BBC and BBP ETFs and ring the Opening Bell

BioShares Launches Two New Biotechnology ETFs (Nasdaq: BBC, BBP)

BioShares Launches Two New Biotechnology ETFs (Nasdaq: BBC, BBP) BioShares Biotechnology Funds give investors unique and selective exposure to the dynamic, high-growth biotechnology sector New York, December 17, 2014 — LifeSci Index Partners, LLC (“LSIP”), a New York City-based investment advisor and index provider, today launched the BioShares™ Biotechnology Clinical Trials Fund (Nasdaq: BBC) and the BioShares™ Biotechnology Products Fund (Nasdaq: BBP) (together, “the Funds”).  The Funds are designed by a team of biotechnology investment specialists and allow investors, for the first time, to choose from two distinct groups of stocks that are typically grouped together in other funds – advanced products stage